Sopharma AD
Pharmaceutical producer of Rx, OTC, and plant-based medicines for international markets.
SFA | BSOBGN
Overview
Corporate Details
- ISIN(s):
- BG11SOSOBT18
- LEI:
- 097900BGGW0000048796
- Country:
- Bulgaria
- Address:
- ул. Лъчезар Станчев 5, кула А, ет.18, 1756 София
- Website:
- https://www.sopharmagroup.com/
- Sector:
- Manufacturing
Description
Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-04-24 23:00 |
097900BGGW0000048796-20231231-BG-CON.zip
|
Bulgarian | 3.2 MB | ||
| 2024-04-22 13:05 |
Sales revenues of Sopharma AD for March 2024
|
English | 83.5 KB | ||
| 2024-04-02 12:24 |
Presentation of the Annual Audited Individual Financial Statements of "Sopharma…
|
Polish | 2.5 MB | ||
| 2024-03-31 23:00 |
608813-SFA_2023_ind_Financial_Report_according_to_BFSC_standards_EN.xls
|
Bulgarian | 322.5 KB | ||
| 2024-03-31 23:00 |
608810-SFA_Annual_ind_financial_statements_2023_BG.pdf
|
Bulgarian | 1.4 MB | ||
| 2024-03-31 23:00 |
608809-SFA_2023_ind_Financial_Report_according_to_BFSC_standards_BG.xlsx
|
Bulgarian | 250.7 KB | ||
| 2024-03-31 23:00 |
608814-SFA_Annual_ind_financial_statements_2023_EN.pdf
|
English | 1.3 MB | ||
| 2024-03-31 23:00 |
608812-097900BGGW0000048796-20231231-EN-SEP.xhtml
|
English | 9.0 MB | ||
| 2024-03-31 23:00 |
608811-SFA_Scorecard_according_to_NCGS_2023_BG.xls
|
Bulgarian | 175.0 KB | ||
| 2024-03-31 23:00 |
097900BGGW0000048796-20231231-BG-SEP.xhtml
|
Bulgarian | 11.1 MB | ||
| 2024-03-20 15:29 |
Sales revenues for February 2024
|
English | 81.7 KB | ||
| 2024-03-12 16:02 |
Incoming transfer from capital increase subject to exercise of warrants from is…
|
English | 143.9 KB | ||
| 2024-03-11 13:56 |
Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (E…
|
Polish | 157.7 KB | ||
| 2024-02-29 13:30 |
Consolidated financial report as of 31 December 2023
|
Polish | 3.1 MB | ||
| 2024-02-27 13:09 |
Results of conditional capital increase of Sopharma AD by exercising warrants f…
|
English | 114.1 KB |
Automate Your Workflow. Get a real-time feed of all Sopharma AD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sopharma AD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sopharma AD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
